{
  "id": "map_1839",
  "title": "UTD - Enfoque Diagn√≥stico de\\NNeutropenia en Adultos",
  "specialty": "Hematolog√≠a",
  "tag": "üìã Gu√≠a Cl√≠nica",
  "node_count": 180,
  "root": {
    "text": "UTD - Enfoque Diagn√≥stico de\\NNeutropenia en Adultos",
    "children": [
      {
        "text": "## DEFINICIONES Y\\NVALORES NORMALES",
        "children": [
          {
            "text": "- **Neutropenia**: Recuento absoluto de neutr√≥filos (RAN) <1500 c√©lulas/microL",
            "children": []
          },
          {
            "text": "- **Clasificaci√≥n**:",
            "children": [
              {
                "text": "- Leve: RAN ‚â•1000 y <1500 c√©lulas/microL",
                "children": []
              },
              {
                "text": "- Moderada: RAN ‚â•500 y <1000 c√©lulas/microL",
                "children": []
              },
              {
                "text": "- Severa: RAN <500 c√©lulas/microL",
                "children": []
              }
            ]
          },
          {
            "text": "- **Agranulocitosis**: RAN <200 c√©lulas/microL",
            "children": []
          },
          {
            "text": "- **Neutropenia cr√≥nica**: Neutropenia durante >3 meses",
            "children": []
          }
        ]
      },
      {
        "text": "## EPIDEMIOLOG√çA",
        "children": [
          {
            "text": "- Prevalencia variable\\Nseg√∫n poblaci√≥n:",
            "children": [
              {
                "text": "- Poblaci√≥n general: 0-10%",
                "children": []
              },
              {
                "text": "- Afroamericanos: 4.5%",
                "children": []
              },
              {
                "text": "- Cauc√°sicos: 0.79%",
                "children": []
              },
              {
                "text": "- M√©xico-americanos: 0.38%",
                "children": []
              }
            ]
          },
          {
            "text": "- Mayor prevalencia en trastornos reumatol√≥gicos",
            "children": []
          }
        ]
      },
      {
        "text": "## MECANISMOS",
        "children": [
          {
            "text": "- Disminuci√≥n de producci√≥n/diferenciaci√≥n en m√©dula √≥sea",
            "children": []
          },
          {
            "text": "- Redistribuci√≥n de neutr√≥filos circulantes (marginaci√≥n)",
            "children": []
          },
          {
            "text": "- Destrucci√≥n inmune",
            "children": []
          }
        ]
      },
      {
        "text": "## CAUSAS DE\\NNEUTROPENIA",
        "children": [
          {
            "text": "### Variantes normales",
            "children": [
              {
                "text": "- Neutropenia asociada al fenotipo Duffy-null (DANC)",
                "children": []
              },
              {
                "text": "- Neutropenia familiar",
                "children": []
              }
            ]
          },
          {
            "text": "### Cong√©nitas",
            "children": [
              {
                "text": "- Neutropenia cong√©nita grave",
                "children": []
              },
              {
                "text": "- S√≠ndrome de Shwachman-Diamond",
                "children": []
              },
              {
                "text": "- Neutropenia c√≠clica",
                "children": []
              }
            ]
          },
          {
            "text": "### Infecciones",
            "children": [
              {
                "text": "- Virales: Hepatitis, VIH, VEB, CMV",
                "children": []
              },
              {
                "text": "- Bacterianas: Especialmente en sepsis",
                "children": []
              },
              {
                "text": "- Parasitarias: Malaria, leishmaniasis",
                "children": []
              }
            ]
          },
          {
            "text": "### Medicamentos",
            "children": [
              {
                "text": "- Predecibles y dosis-dependientes: Agentes citot√≥xicos",
                "children": []
              },
              {
                "text": "- Idiosincr√°ticas: M√∫ltiples f√°rmacos",
                "children": []
              }
            ]
          },
          {
            "text": "### Nutricionales",
            "children": [
              {
                "text": "- D√©ficit de vitamina B12",
                "children": []
              },
              {
                "text": "- D√©ficit de folato",
                "children": []
              },
              {
                "text": "- D√©ficit de cobre",
                "children": []
              }
            ]
          },
          {
            "text": "### Neoplasias\\Nhematol√≥gicas",
            "children": [
              {
                "text": "- Leucemia de linfocitos grandes granulares (LGL)",
                "children": []
              },
              {
                "text": "- Leucemia de c√©lulas peludas",
                "children": []
              },
              {
                "text": "- S√≠ndromes mielodispl√°sicos",
                "children": []
              }
            ]
          },
          {
            "text": "### Trastornos\\Nreumatol√≥gicos",
            "children": [
              {
                "text": "- Artritis reumatoide",
                "children": []
              },
              {
                "text": "- Lupus eritematoso sist√©mico",
                "children": []
              },
              {
                "text": "- S√≠ndrome de Felty",
                "children": []
              }
            ]
          },
          {
            "text": "### Otras causas",
            "children": [
              {
                "text": "- Neutropenia autoinmune",
                "children": []
              },
              {
                "text": "- Anemia apl√°sica",
                "children": []
              },
              {
                "text": "- Neutropenia idiop√°tica cr√≥nica",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## EVALUACI√ìN\\NINICIAL",
        "children": [
          {
            "text": "### Urgencia de\\Nevaluaci√≥n",
            "children": [
              {
                "text": "- **Inmediata**: Signos de sepsis, inestabilidad hemodin√°mica, RAN <500 c√©lulas/microL",
                "children": []
              },
              {
                "text": "- **1-2 semanas**: Neutropenia moderada asintom√°tica",
                "children": []
              },
              {
                "text": "- **2-6 semanas**: Neutropenia leve asintom√°tica",
                "children": []
              }
            ]
          },
          {
            "text": "###\\NHemograma\\Ncompleto",
            "children": [
              {
                "text": "- Confirmar nivel de RAN",
                "children": []
              },
              {
                "text": "- Revisar hemogramas previos",
                "children": []
              },
              {
                "text": "- Evaluar otras citopenias\\Nacompa√±antes:",
                "children": [
                  {
                    "text": "- Eosinofilia/basofilia",
                    "children": []
                  },
                  {
                    "text": "- Linfocitosis/linfopenia",
                    "children": []
                  },
                  {
                    "text": "- Anemia (macroc√≠tica, apl√°sica, mieloft√≠sica)",
                    "children": []
                  },
                  {
                    "text": "- Trombocitopenia",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "### Historia cl√≠nica",
            "children": [
              {
                "text": "- Infecciones activas o previas",
                "children": []
              },
              {
                "text": "- √ölceras aftosas epis√≥dicas",
                "children": []
              },
              {
                "text": "- Neoplasias hematol√≥gicas diagnosticadas",
                "children": []
              },
              {
                "text": "- Trastornos gastrointestinales",
                "children": []
              },
              {
                "text": "- Medicamentos (relaci√≥n temporal)",
                "children": []
              },
              {
                "text": "- Exposiciones personales y ocupacionales",
                "children": []
              },
              {
                "text": "- Historia familiar de neutropenia",
                "children": []
              },
              {
                "text": "- Origen √©tnico",
                "children": []
              }
            ]
          },
          {
            "text": "### Examen f√≠sico",
            "children": [
              {
                "text": "- Signos de infecci√≥n:",
                "children": [
                  {
                    "text": "- Fiebre",
                    "children": []
                  },
                  {
                    "text": "- Alteraciones cut√°neas",
                    "children": []
                  },
                  {
                    "text": "- Gingivitis, √∫lceras orales",
                    "children": []
                  },
                  {
                    "text": "- Examen respiratorio anormal",
                    "children": []
                  }
                ]
              },
              {
                "text": "- Signos diagn√≥sticos:",
                "children": [
                  {
                    "text": "- Ictericia o estigmas de hepatopat√≠a",
                    "children": []
                  },
                  {
                    "text": "- Inflamaci√≥n articular",
                    "children": []
                  },
                  {
                    "text": "- Erupciones cut√°neas",
                    "children": []
                  },
                  {
                    "text": "- Linfadenopat√≠a o esplenomegalia",
                    "children": []
                  },
                  {
                    "text": "- Alteraciones neuropsiqui√°tricas",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "### Frotis de\\Nsangre perif√©rica",
            "children": [
              {
                "text": "- Morfolog√≠a\\Nneutrof√≠lica:",
                "children": [
                  {
                    "text": "- Granulaciones t√≥xicas o cuerpos de Dohle (sepsis)",
                    "children": []
                  },
                  {
                    "text": "- Neutr√≥filos bilobulados o displ√°sicos (SMD)",
                    "children": []
                  },
                  {
                    "text": "- Neutr√≥filos hipersegmentados (d√©ficit B12/folato)",
                    "children": []
                  },
                  {
                    "text": "- C√©lulas mieloides inmaduras (leucemia)",
                    "children": []
                  }
                ]
              },
              {
                "text": "- Morfolog√≠a\\Nlinfocitaria:",
                "children": [
                  {
                    "text": "- Linfocitos at√≠picos (viral)",
                    "children": []
                  },
                  {
                    "text": "- Linfocitos \"smudge\" (LLC)",
                    "children": []
                  },
                  {
                    "text": "- Proyecciones \"pilosas\" (tricoleucemia)",
                    "children": []
                  },
                  {
                    "text": "- Linfocitos con gr√°nulos azur√≥filos (LGL)",
                    "children": []
                  }
                ]
              },
              {
                "text": "- Gl√≥bulos\\Nrojos:",
                "children": [
                  {
                    "text": "- Macro-ovalocitos (anemias megalobl√°sticas)",
                    "children": []
                  },
                  {
                    "text": "- C√©lulas fragmentadas (microangiopat√≠a)",
                    "children": []
                  },
                  {
                    "text": "- Dacriocitos (procesos mieloft√≠sicos)",
                    "children": []
                  },
                  {
                    "text": "- C√©lulas espiculadas o en diana (hepatopat√≠a)",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "### Otras\\Npruebas iniciales",
            "children": [
              {
                "text": "- Deficiencia\\Nnutricional:",
                "children": [
                  {
                    "text": "- Niveles de vitamina B12, folato y cobre",
                    "children": []
                  },
                  {
                    "text": "- Pruebas de funci√≥n hep√°tica",
                    "children": []
                  },
                  {
                    "text": "- Cribado para hepatitis viral y VIH",
                    "children": []
                  }
                ]
              },
              {
                "text": "- Pacientes\\Nfebriles/inestables:",
                "children": [
                  {
                    "text": "- Pruebas de coagulaci√≥n",
                    "children": []
                  },
                  {
                    "text": "- LDH y creatinina s√©rica",
                    "children": []
                  },
                  {
                    "text": "- VSG y/o PCR en neutropenia moderada/severa",
                    "children": []
                  },
                  {
                    "text": "- Tipaje sangu√≠neo para ant√≠geno Duffy en casos sugestivos",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "## EVALUACI√ìN\\NPOSTERIOR Y MANEJO",
        "children": [
          {
            "text": "### Diagn√≥stico\\Nestablecido",
            "children": [
              {
                "text": "- **Deficiencia nutricional**: Suplementaci√≥n apropiada",
                "children": []
              },
              {
                "text": "- **Infecci√≥n viral**: Mejora en 1-2 semanas",
                "children": []
              },
              {
                "text": "- **Medicamentos**:",
                "children": [
                  {
                    "text": "- RAN <1000: Suspender medicamentos asociados a reacciones idiosincr√°ticas",
                    "children": []
                  },
                  {
                    "text": "- RAN ‚â•1000: Suspender citot√≥xicos/inmunosupresores",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "### Otros escenarios",
            "children": [
              {
                "text": "#### Paciente\\Nhospitalizado",
                "children": [
                  {
                    "text": "- Determinar si es previa o desarrollada durante hospitalizaci√≥n",
                    "children": []
                  },
                  {
                    "text": "- Correlacionar con medicamentos",
                    "children": []
                  },
                  {
                    "text": "- Considerar derivaci√≥n a hematolog√≠a si no hay mejor√≠a",
                    "children": []
                  }
                ]
              },
              {
                "text": "#### Neutropenia\\Nincidental asintom√°tica",
                "children": [
                  {
                    "text": "- RAN ‚â•1000: Evaluaci√≥n ambulatoria",
                    "children": []
                  },
                  {
                    "text": "- Si mejora: Probable s√≠ndrome viral o medicaci√≥n mielosupresora",
                    "children": []
                  },
                  {
                    "text": "- Si es estable: Considerar DANC, neutropenia familiar, autoinmune",
                    "children": []
                  }
                ]
              },
              {
                "text": "#### Frotis anormal/Hemograma\\Nalterado",
                "children": [
                  {
                    "text": "- Hallazgos sugestivos de leucemia: Hospitalizaci√≥n inmediata",
                    "children": []
                  },
                  {
                    "text": "- Esquistocitos: Hospitalizaci√≥n inmediata",
                    "children": []
                  },
                  {
                    "text": "- Granulaciones t√≥xicas: Evaluaci√≥n urgente",
                    "children": []
                  },
                  {
                    "text": "- C√©lulas displ√°sicas o at√≠picas: Derivaci√≥n hematol√≥gica",
                    "children": []
                  }
                ]
              },
              {
                "text": "#### Infecci√≥n/fiebre",
                "children": [
                  {
                    "text": "- Temperatura ‚â•38.0¬∞C: Tratamiento antibi√≥tico inmediato",
                    "children": []
                  },
                  {
                    "text": "- Sepsis/inestabilidad: Hospitalizaci√≥n inmediata",
                    "children": []
                  }
                ]
              },
              {
                "text": "#### Trastornos\\Nreumatol√≥gicos/autoinmunes",
                "children": [
                  {
                    "text": "- Evaluaci√≥n de manifestaciones\\Nhematol√≥gicas espec√≠ficas",
                    "children": []
                  }
                ]
              },
              {
                "text": "#### Sospecha de\\Nneutropenia cong√©nita",
                "children": [
                  {
                    "text": "- Considerar en neutropenia severa inexplicada",
                    "children": []
                  },
                  {
                    "text": "- Buscar hallazgos som√°ticos o antecedentes familiares",
                    "children": []
                  },
                  {
                    "text": "- Derivar a hemat√≥logo con experiencia en estos trastornos",
                    "children": []
                  }
                ]
              },
              {
                "text": "#### Variantes normales <1500/microL",
                "children": [
                  {
                    "text": "- DANC: Recuento estable, sin infecciones, asociado al fenotipo Duffy-null",
                    "children": []
                  },
                  {
                    "text": "- Neutropenia familiar: Similar pero en grupos √©tnicos no asociados a DANC",
                    "children": []
                  },
                  {
                    "text": "- Diagn√≥stico: RAN persistente <1500/microL sin historia de infecciones anormales",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "## EVALUACI√ìN\\NADICIONAL",
        "children": [
          {
            "text": "### Derivaci√≥n a\\Nhematolog√≠a",
            "children": [
              {
                "text": "- **Inmediata (horas)**:",
                "children": [
                  {
                    "text": "- Blastos leuc√©micos en frotis",
                    "children": []
                  },
                  {
                    "text": "- Agranulocitosis (RAN <200/microL)",
                    "children": []
                  }
                ]
              },
              {
                "text": "- **Pronta (d√≠as)**:",
                "children": [
                  {
                    "text": "- Anomal√≠as en frotis sugestivas de neoplasia hematol√≥gica",
                    "children": []
                  },
                  {
                    "text": "- Pancitopenia",
                    "children": []
                  },
                  {
                    "text": "- Hallazgos de s√≠ndrome de neutropenia cong√©nita",
                    "children": []
                  }
                ]
              },
              {
                "text": "- **Oportuna\\N(d√≠as-semanas)**:",
                "children": [
                  {
                    "text": "- Empeoramiento o persistencia de RAN <1000/microL no explicada",
                    "children": []
                  },
                  {
                    "text": "- Respuesta inadecuada a tratamiento nutricional",
                    "children": []
                  },
                  {
                    "text": "- Patr√≥n de infecciones epis√≥dicas consistente con neutropenia c√≠clica",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "### Examen de\\Nm√©dula √≥sea",
            "children": [
              {
                "text": "- **Esencial**: Sospecha de trastorno hematol√≥gico primario o s√≠ndrome de neutropenia cong√©nita",
                "children": []
              },
              {
                "text": "- **√ötil**: Sospecha de infecci√≥n f√∫ngica o tuberculosis",
                "children": []
              },
              {
                "text": "- **Puede ser enga√±oso**: Realizado muy pronto tras suspensi√≥n de medicamento",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## RIESGO DE\\NINFECCI√ìN",
        "children": [
          {
            "text": "- Influenciado por severidad y trayectoria del RAN",
            "children": []
          },
          {
            "text": "- Afectado por causa subyacente",
            "children": []
          },
          {
            "text": "- Mayor riesgo: Defectos de producci√≥n vs. redistribuci√≥n/inmune",
            "children": []
          }
        ]
      },
      {
        "text": "## MONITORIZACI√ìN",
        "children": [
          {
            "text": "- **Neutropenia no\\Ncomplicada**:",
            "children": [
              {
                "text": "- Hemogramas semanales durante 2-4 semanas",
                "children": []
              },
              {
                "text": "- Repetir a los 3 meses",
                "children": []
              }
            ]
          },
          {
            "text": "- **Si se resuelve**: No requiere seguimiento adicional",
            "children": []
          },
          {
            "text": "- **DANC**: No requiere monitorizaci√≥n adicional",
            "children": []
          },
          {
            "text": "- **Otras causas definidas**: Guiada por enfermedad subyacente",
            "children": []
          }
        ]
      },
      {
        "text": "## RESUMEN",
        "children": [
          {
            "text": "- La neutropenia puede reflejar defectos de producci√≥n, redistribuci√≥n o destrucci√≥n",
            "children": []
          },
          {
            "text": "- La evaluaci√≥n inicial debe estratificar el riesgo seg√∫n severidad, s√≠ntomas y hallazgos",
            "children": []
          },
          {
            "text": "- Los medicamentos y las infecciones son causas frecuentes y potencialmente reversibles",
            "children": []
          },
          {
            "text": "- Las variantes normales (DANC) son comunes en ciertos grupos √©tnicos",
            "children": []
          },
          {
            "text": "- El riesgo de infecci√≥n se correlaciona principalmente con la severidad y causa de neutropenia",
            "children": []
          },
          {
            "text": "- La evaluaci√≥n de m√©dula √≥sea est√° indicada en casos seleccionados",
            "children": []
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1689",
      "title": "SPRINTT (2021)\\NSarcopenia and Physical\\NFragility in Older People:\\NMulti-component Treatment\\N\\n‚≠ê Ejercicio + nutrici√≥n reduce\\ndiscapacidad en fragilidad f√≠sica\\ncon sarcopenia"
    },
    {
      "id": "map_1836",
      "title": "Inmunoglobulina Intravenosa (IVIg) como Terapia de\\NRescate en Anemia Hemol√≠tica Autoinmune (AHAI) Grave\\Ndel Adulto: Estudio Observacional Multic√©ntrico Franc√©s\\N**(Publicado 2024)**"
    },
    {
      "id": "map_1427",
      "title": "Inmunoglobulina Intravenosa (IVIg) como Terapia de Rescate en Anemia Hemol√≠tica Autoinmune (AHAI) Grave del Adulto: Estudio Observacional Multic√©ntrico Franc√©s **(Publicado 2024)**"
    },
    {
      "id": "map_1633",
      "title": "ACV: ESCALAS DE UTILIDAD CL√çNICA"
    },
    {
      "id": "map_1673",
      "title": "DAPA-CKD (2020)\\NDapagliflozin And Prevention\\Nof Adverse outcomes in CKD\\N\\N‚≠ê iSGLT2 protege ri√±√≥n\\NINCLUSO SIN DIABETES\\N(Extiende beneficio a ERC no-DM)"
    }
  ],
  "source_file": "UTD - Enfoque DiagnoÃÅstico de Neutropenia en Adultos-2025.smmx",
  "created": "2026-02-07T15:43:00.022292"
}